Osaic Holdings’s Solid Biosciences SLDB Stock Holding History

Osaic Holdings’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.2K	Sell	1,322 -141	-10%	-$1.07K	﹤0.01%	6442
2026 Q1	$10.5K	Sell	1,463 -554	-27%	-$3.56K	﹤0.01%	6258
2025 Q4	$11.4K	Buy	2,017 +1,987	+6,623%	+$10.8K	﹤0.01%	6261
2025 Q3	$178	Hold	30	–	–	﹤0.01%	7704
2025 Q2	$145	Hold	30	–	–	﹤0.01%	7536
2025 Q1	$110	Hold	30	–	–	﹤0.01%	7229
2024 Q4	$120	Hold	30	–	–	﹤0.01%	7231
2024 Q3	$208	Hold	30	–	–	﹤0.01%	7165
2024 Q2	$170	Hold	30	–	–	﹤0.01%	7186
2024 Q1	$399	Hold	30	–	–	﹤0.01%	6865
2023 Q4	$184	Hold	30	–	–	﹤0.01%	7054
2023 Q3	$75	Hold	30	–	–	﹤0.01%	7252
2023 Q2	$156	Sell	30 -128	-81%	-$720	﹤0.01%	7241
2023 Q1	$748	Buy	158 +128	+427%	+$769	﹤0.01%	7044
2022 Q4	$0	Sell	30 -1	-3%	-$7	﹤0.01%	7405
2022 Q3	$0	Hold	31	–	–	﹤0.01%	7486
2022 Q2	$0	Hold	31	–	–	﹤0.01%	7568
2022 Q1	$0	Buy	31 +7	+29%	+$124	﹤0.01%	7471
2021 Q4	$1K	Hold	24	–	–	﹤0.01%	7240
2021 Q3	$1K	Hold	24	–	–	﹤0.01%	7069
2021 Q2	$1K	Hold	24	–	–	﹤0.01%	6880
2021 Q1	$2K	Hold	24	–	–	﹤0.01%	6521
2020 Q4	$3K	Hold	24	–	–	﹤0.01%	5982
2020 Q3	$1K	Hold	24	–	–	﹤0.01%	6066
2020 Q2	$1K	Hold	24	–	–	﹤0.01%	5979
2020 Q1	$1K	Buy	+24	New	+$1.19K	﹤0.01%	5908

Other funds holding SLDB

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Osaic Holdings's SLDB Position: Q2 2026 in Review

Osaic Holdings reduced its Solid Biosciences (SLDB) stake by 9.6% in Q2 2026, selling an estimated $1.07K and leaving 1,322 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #6442.

Osaic Holdings first reported a position in SLDB in Q1 2020 and has held it in 26 quarters since. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

Osaic Holdings held 1,322 shares of Solid Biosciences worth $13.2K as of Q2 2026.
Osaic Holdings sold 141 Solid Biosciences shares in Q2 2026, an estimated $1.07K.
Solid Biosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6442 holding.
Osaic Holdings first reported a position in Solid Biosciences in Q1 2020 and has held it in 26 quarters since.
157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.